Reviews in the Neurosciences

Papers
(The H4-Index of Reviews in the Neurosciences is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Probiotic effects on anxiety-like behavior in animal models59
Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication31
Putative neural consequences of captivity for elephants and cetaceans29
A systematic review of transcranial direct current stimulation on eye movements and associated psychological function28
Research progress on astrocyte-derived extracellular vesicles in the pathogenesis and treatment of neurodegenerative diseases26
Targeting NMDA receptor signaling for therapeutic intervention in brain disorders24
Frontmatter23
Scoping review of the risk factors and time frame for development of post-traumatic hydrocephalus21
Advances in point-of-care platforms for traumatic brain injury: recent developments in diagnostics20
Research advancements on nerve guide conduits for nerve injury repair19
Advanced techniques and innovations in peripheral nerve repair: a comprehensive review for clinical and experimental reference18
Dominant mechanism in spinal cord injury-induced immunodeficiency syndrome (SCI-IDS): sympathetic hyperreflexia18
The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses18
Simulation of oscillatory dynamics induced by an approximation of grid cell output18
Extracellular histones as damage-associated molecular patterns in neuroinflammatory responses18
Adult ADHD: it is old and new at the same time – what is it?17
Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis17
An overview of retinal light damage models for preclinical studies on age-related macular degeneration: identifying molecular hallmarks and therapeutic targets17
0.036211967468262